GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: Cefizox® | compound 22 {PMID: 2342058] | Epocelin® | FK-749 | FK749 | FR-13749 | FR13749 | SK&F 88373-Z
ceftizoxime is an approved drug (FDA (1983))
Compound class:
Synthetic organic
Comment: Ceftizoxime is a semisynthetic, broad-spectrum, β-lactamase-resistant, parenterally administered third-generation cephalosporin antibacterial with Gram +ve and Gram -ve activity. Unlike other third-generation cephalosporins, ceftizoxime's C-3 side chain has been removed to prevent deactivation by hydrolytic enzymes.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes. US FDA (1983) |
| Withdrawn drug? | Yes |
| Prodrug | ceftizoxime alapivoxil |
IUPAC Name ![]() |
| (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 4743 | ceftizoxime |
Synonyms ![]() |
| Cefizox® | compound 22 {PMID: 2342058] | Epocelin® | FK-749 | FK749 | FR-13749 | FR13749 | SK&F 88373-Z |
Database Links ![]() |
|
| BindingDB Ligand | 237182 |
| CAS Registry No. | 68401-81-0 (source: WHO INN record) |
| ChEMBL Ligand | CHEMBL528 |
| DrugCentral Ligand | 563 |
| GtoPdb PubChem SID | 405560226 |
| PubChem CID | 6533629 |
| Search Google for chemical match using the InChIKey | NNULBSISHYWZJU-LLKWHZGFSA-N |
| Search Google for chemicals with the same backbone | NNULBSISHYWZJU |
| Search PubMed clinical trials | ceftizoxime |
| Search PubMed titles | ceftizoxime |
| Search PubMed titles/abstracts | ceftizoxime |
| UniChem Compound Search for chemical match using the InChIKey | NNULBSISHYWZJU-LLKWHZGFSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | NNULBSISHYWZJU-LLKWHZGFSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖|
Ceftizoxime (links to external site)
Cat. No. HY-B1596 |